Cns Pharmaceuticals Inc [NASDAQ: CNSP] closed the trading session at $0.19.
The stocks have a year to date performance of -99.69 percent and weekly performance of -81.33 percent. The stock has been moved at -98.45 percent over the last six months. The stock has performed -84.08 percent around the most recent 30 days and changed -98.24 percent over the most recent 3-months.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
If compared to the average trading volume of 3.01M shares, CNSP reached to a volume of 51595373 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Cns Pharmaceuticals Inc [CNSP]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for CNSP shares is $1500.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on CNSP stock is a recommendation set at 3.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Ladenburg Thalmann have made an estimate for Cns Pharmaceuticals Inc shares, keeping their opinion on the stock as Neutral, with their previous recommendation back on December 28, 2020. While these analysts kept the previous recommendation, Ladenburg Thalmann raised their target price to Buy. The new note on the price target was released on August 24, 2020, representing the official price target for Cns Pharmaceuticals Inc stock.
CNSP stock trade performance evaluation
Cns Pharmaceuticals Inc [CNSP] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -81.33. With this latest performance, CNSP shares dropped by -84.08% in over the last four-week period, additionally sinking by -98.45% over the last 6 months – not to mention a drop of -99.82% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for CNSP stock in for the last two-week period is set at 19.34, with the RSI for the last a single of trading hit 13.40, and the three-weeks RSI is set at 23.31 for Cns Pharmaceuticals Inc [CNSP]. The present Moving Average for the last 50 days of trading for this stock 3.0654, while it was recorded at 0.2925 for the last single week of trading, and 34.1211 for the last 200 days.
Cns Pharmaceuticals Inc [CNSP]: An insightful look at the core fundamentals
Cns Pharmaceuticals Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 0.26 and a Current Ratio set at 0.26.
Cns Pharmaceuticals Inc [CNSP]: Institutional Ownership
The top three institutional holders of CNSP stocks are: VANGUARD GROUP INC with ownership of 1.32 billion shares, which is approximately 8.5034%. BLACKROCK INC., holding 1.04 billion shares of the stock with an approximate value of $178.43 billion in CNSP stocks shares; and BERKSHIRE HATHAWAY INC, currently with $135.36 billion in CNSP stock with ownership which is approximately 5.1238%.
